EUVIMEDEUVIMED entdecken
Crossref

Kratom ( Mitragyna speciosa ): A Case Review of Use Before and During Pregnancy

Mary Ann Faucher iD, Stephanie Morillos, Polly Cordova, Jessica McNeil-Santiel, Nancy Onisko, Emily H Adhikari, David B Nelson

Journal of Midwifery & Women's Health · 2024

DOI: 10.1111/jmwh.13558 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Midwifery & Women's Health, 2024. Verfasst von Mary Ann Faucher und 6 weiteren Autor:innen. Beteiligte Einrichtung: Women & Infants Specialty Health, Parkland Health, Dallas, Texas. Hauptthemen laut MEDLINE: Mitragyna, Substance Withdrawal Syndrome, Opioid-Related Disorders. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 33 Literaturangaben. Gefördert von: Texas Targeted Opioid Response, Health & Human Services Commission.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kratom ( Mitragyna speciosa ) is a plant‐based substance with psychoactive properties similar to opioids but is not currently classified as an opioid. One of its more prevalent uses is to treat opioid dependency and withdrawal symptoms. Opioid use disorder is a leading cause of pregnancy‐associated maternal mortality, and pregnant women may be using kratom as a substitute or alternative to opioids. Prevalence of kratom use is increasing rapidly, but scientific evidence specific to therapeutic and adverse effects is lacking overall, and the implications of its use in pregnancy and on the fetus‐newborn are limited to a few case reports. Kratom is a legal substance by federal law, although some states have banned its use. The lack of regulation is concerning. Significant illness and associated deaths have been reported with kratom use. Lack of disclosure by people using kratom and limited laboratory testing options are major challenges for health care providers and public health.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MitragynaSubstance Withdrawal SyndromeOpioid-Related DisordersInfant, NewbornHumansFemalePregnancyAnalgesics, OpioidHealth Personnel

Substanzen

Analgesics, Opioid

Autor:innen und Institutionen

  • Women & Infants Specialty Health, Parkland Health, Dallas, Texas.
  • Department of Emergency Medicine, University of Texas Southwestern Medical Center, Dallas, Texas.
  • Department of Obstetrics & Gynecology, University of Texas Southwestern Medical Center, Dallas, Texas.
  • Division of Maternal-Fetal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas.

ORCID-Profile: Mary Ann Faucher

Förderung

  • Texas Targeted Opioid Response, Health & Human Services Commission

Zitieren

APA

Faucher, M. A., Morillos, S., Cordova, P., McNeil-Santiel, J., Onisko, N., Adhikari, E. H., & Nelson, D. B. (2024). Kratom ( Mitragyna speciosa ): A Case Review of Use Before and During Pregnancy. Journal of Midwifery & Women's Health. https://doi.org/10.1111/jmwh.13558

Vancouver

Faucher MA, Morillos S, Cordova P, McNeil-Santiel J, Onisko N, Adhikari EH, et al. Kratom ( Mitragyna speciosa ): A Case Review of Use Before and During Pregnancy. Journal of Midwifery & Women's Health. 2024. doi:10.1111/jmwh.13558

BibTeX
@article{Faucher2024,
  author = {Faucher, Mary Ann and Morillos, Stephanie and Cordova, Polly and McNeil-Santiel, Jessica and Onisko, Nancy and Adhikari, Emily H and Nelson, David B},
  title = {Kratom ( Mitragyna speciosa ): A Case Review of Use Before and During Pregnancy},
  journal = {Journal of Midwifery & Women's Health},
  year = {2024},
  doi = {10.1111/jmwh.13558}
}
Kostenlos starten →